Pyruvate inhibits clofibrate-induced hepatic peroxisomal proliferation and free radical production in rats.

[1]  R. Stanko,et al.  Hemodynamic effects of intravenous pyruvate in the intact, anesthetized dog , 1994, Critical care medicine.

[2]  J. Janosky,et al.  Pyruvate inhibits growth of mammary adenocarcinoma 13762 in rats. , 1994, Cancer research.

[3]  J. Albina,et al.  Nitric oxide-mediated apoptosis in murine peritoneal macrophages. , 1993, Journal of immunology.

[4]  H. Kolb,et al.  Islet Cell DNA Is a Target of Inflammatory Attack by Nitric Oxide , 1993, Diabetes.

[5]  T. Billiar,et al.  Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia , 1992, Critical care medicine.

[6]  R. Stanko,et al.  Body composition, nitrogen metabolism, and energy utilization with feeding of mildly restricted (4.2 MJ/d) and severely restricted (2.1 MJ/d) isonitrogenous diets. , 1992, The American journal of clinical nutrition.

[7]  R. Stanko,et al.  Body composition, energy utilization, and nitrogen metabolism with a 4.25-MJ/d low-energy diet supplemented with pyruvate. , 1992, The American journal of clinical nutrition.

[8]  J. Gustafsson,et al.  Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Stanko,et al.  Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate. , 1992, The American journal of clinical nutrition.

[10]  Christine Dreyer,et al.  Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.

[11]  S. Green.  Receptor-mediated mechanisms of peroxisome proliferators. , 1992, Biochemical pharmacology.

[12]  R J Robertson,et al.  Enhanced leg exercise endurance with a high-carbohydrate diet and dihydroxyacetone and pyruvate. , 1990, Journal of applied physiology.

[13]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.

[14]  T. Billiar,et al.  Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. , 1990, Biochemical and biophysical research communications.

[15]  C. Pichard,et al.  Vitamin E suppresses increased lipid peroxidation in cigarette smokers. , 1990, JPEN. Journal of parenteral and enteral nutrition.

[16]  R. Bünger,et al.  Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure. , 1989, European journal of biochemistry.

[17]  J. Reddy,et al.  Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. , 1988, Cancer research.

[18]  B. Ames,et al.  Oxygen radicals and human disease. , 1987, Annals of internal medicine.

[19]  B. Lake,et al.  Effect of prolonged administration of clofibric acid and di-(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat. , 1987, Toxicology.

[20]  C. Elcombe,et al.  Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. , 1986, Carcinogenesis.

[21]  J. Reddy,et al.  Peroxisome proliferation and lipid peroxidation in rat liver. , 1986, Cancer research.

[22]  R. Simon,et al.  OXIDANT ACTIVITY IN EXPIRED BREATH OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME , 1986, The Lancet.

[23]  J. McCord,et al.  Oxygen-derived free radicals in postischemic tissue injury. , 1985, The New England journal of medicine.

[24]  T. Orton,et al.  Clobuzarit: species differences in the morphological and biochemical response of the liver following chronic administration. , 1984, Toxicology and applied pharmacology.

[25]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[26]  J. Thorp,et al.  ANALYTICAL SUBCELLULAR FRACTIONATION AND ENZYMIC ANALYSIS OF LIVER HOMOGENATES FROM CONTROL AND CLOFIBRATE‐TREATED RATS, MICE, AND MONKEYS WITH REFERENCE TO THE FATTY ACID‐OXIDIZING ENZYMES , 1982 .

[27]  R. Stanko,et al.  Prevention of alcohol-induced fatty liver by natural metabolites and riboflavin. , 1978, The Journal of laboratory and clinical medicine.

[28]  F. Leighton,et al.  THE LARGE-SCALE SEPARATION OF PEROXISOMES, MITOCHONDRIA, AND LYSOSOMES FROM THE LIVERS OF RATS INJECTED WITH TRITON WR-1339 , 1968, The Journal of cell biology.

[29]  J. Gerich,et al.  Effect of dihydroxyacetone and pyruvate on plasma glucose concentration and turnover in noninsulin-dependent diabetes mellitus. , 1990, Clinical physiology and biochemistry.

[30]  R. Robertson,et al.  Enhancement of arm exercise endurance capacity with dihydroxyacetone and pyruvate. , 1990, Journal of applied physiology.

[31]  M. Rao,et al.  The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis. , 1989, Drug metabolism reviews.

[32]  E. Lock,et al.  Biochemical mechanisms of induction of hepatic peroxisome proliferation. , 1989, Annual review of pharmacology and toxicology.

[33]  C. Dillard,et al.  [41] Fluorescent damage products of lipid peroxidation , 1984 .

[34]  P. Lazarow.  Assay of peroxisomal beta-oxidation of fatty acids. , 1981, Methods in enzymology.